Travere Therapeutics Inc logo

Travere Therapeutics Inc

NAS:TVTX (USA)   Ordinary Shares
$ 6.94 -0.15 (-2.11%) 11:09 PM EST
At Loss
P/B:
7.16
Market Cap:
$ 528.34M
Enterprise V:
$ 503.49M
Volume:
816.19K
Avg Vol (2M):
1.15M
Trade In:
Volume:
816.19K
At Loss
Avg Vol (2M):
1.15M

Business Description

Travere Therapeutics Inc logo
Travere Therapeutics Inc
NAICS : 325411 SIC : 2834
ISIN : US89422G1076

Share Class Description:

TVTX: Ordinary Shares
Description
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
Name Current Vs Industry Vs History
Cash-To-Debt 1.09
Equity-to-Asset 0.11
Debt-to-Equity 5.45
Debt-to-EBITDA -1.17
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.21
Distress
Grey
Safe
Beneish M-Score -1.29
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 34.93
9-Day RSI 44.91
14-Day RSI 48.94
6-1 Month Momentum % -26.02
12-1 Month Momentum % -64.54

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.78
Quick Ratio 2.75
Cash Ratio 2.55
Days Inventory 470.1
Days Sales Outstanding 40.01
Days Payable 935.47

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13
Shareholder Yield % 0.45

Financials (Next Earnings Date:2024-08-02 Est.)

TVTX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TVTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Travere Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 183.225
EPS (TTM) ($) -2.1
Beta 0.8
Volatility % 85.09
14-Day RSI 48.94
14-Day ATR ($) 0.404279
20-Day SMA ($) 7.107
12-1 Month Momentum % -64.54
52-Week Range ($) 5.12 - 17.5699
Shares Outstanding (Mil) 76.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Travere Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Travere Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Travere Therapeutics Inc Frequently Asked Questions

What is Travere Therapeutics Inc(TVTX)'s stock price today?
The current price of TVTX is $6.94. The 52 week high of TVTX is $17.57 and 52 week low is $5.12.
When is next earnings date of Travere Therapeutics Inc(TVTX)?
The next earnings date of Travere Therapeutics Inc(TVTX) is 2024-08-02 Est..
Does Travere Therapeutics Inc(TVTX) pay dividends? If so, how much?
Travere Therapeutics Inc(TVTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1